BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12676884)

  • 1. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
    Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
    Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
    J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
    Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
    Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
    Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
    Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
    Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
    Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
    Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
    Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
    Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
    Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
    Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
    Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
    Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
    Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
    Ogese MO; Saide K; Faulkner L; Whitaker P; Peckham D; Alfirevic A; Baker DM; Sette A; Pirmohamed M; Park BK; Naisbitt DJ
    Clin Exp Allergy; 2015 Aug; 45(8):1305-16. PubMed ID: 25851465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
    Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
    Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals.
    Engler OB; Strasser I; Naisbitt DJ; Cerny A; Pichler WJ
    Toxicology; 2004 Apr; 197(1):47-56. PubMed ID: 15003333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
    Schmid DA; Depta JP; Lüthi M; Pichler WJ
    Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity.
    Depta JP; Altznauer F; Gamerdinger K; Burkhart C; Weltzien HU; Pichler WJ
    J Allergy Clin Immunol; 2004 Mar; 113(3):519-27. PubMed ID: 15007356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat.
    Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.